Nathalie Marin

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jérôme Hadjadj, Nader Yatim, Laura Barnabei et al. · Science · 2020 · 3.2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore et al. · Cell · 2020 · 920 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +5

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux et al. · JAMA Internal Medicine · 2020 · 777 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries

Vincenzo Russotto, Sheila Nainan Myatra, John G. Laffey et al. · JAMA · 2021 · 619 citations · Full text

Medicine, Emergency Medicine, Critical Care Anesthesiology +12

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 296 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +14